SEC Filings

10-Q
MEDTRONIC PLC filed this Form 10-Q on 09/01/2017
Entire Document
 
Medtronic plc
Notes to Consolidated Financial Statements
(Unaudited)


Condensed Consolidating Statement of Cash Flows
Three Months Ended July 28, 2017
CIFSA Senior Notes
(in millions)
Medtronic plc
 
CIFSA
 
CIFSA Subsidiary Guarantors
 
Subsidiary Non-guarantors
 
Consolidating
Adjustments
 
Total
Operating Activities:
 
 
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
$
24

 
$
234

 
$
88

 
$
641

 
$
(250
)
 
$
737

Investing Activities:
 
 
 
 
 
 
 
 
 
 
 
Acquisitions, net of cash acquired

 

 

 

 

 

Additions to property, plant, and equipment

 

 

 
(278
)
 

 
(278
)
Purchases of investments

 

 

 
(615
)
 

 
(615
)
Sales and maturities of investments

 

 

 
971

 

 
971

Net (increase) decrease in intercompany loans

 
183

 
(2,007
)
 
(1,374
)
 
3,198

 

Capital contribution paid

 
(452
)
 

 

 
452

 

Other investing activities, net

 

 

 
5

 

 
5

Net cash provided by (used in) investing activities

 
(269
)
 
(2,007
)
 
(1,291
)
 
3,650

 
83

Financing Activities:
 
 
 
 
 
 
 
 
 
 
 
Acquisition-related contingent consideration

 

 

 
(3
)
 

 
(3
)
Change in current debt obligations, net

 

 
572

 
(3
)
 

 
569

Issuance of long-term debt

 

 

 
18

 

 
18

Payments on long-term debt

 

 

 
(8
)
 

 
(8
)
Dividends to shareholders
(625
)
 

 

 

 

 
(625
)
Issuance of ordinary shares
143

 

 

 

 

 
143

Repurchase of ordinary shares
(1,233
)
 

 

 

 

 
(1,233
)
Net intercompany loan borrowings (repayments)
1,691

 
2

 
1,372

 
133

 
(3,198
)
 

Intercompany dividend paid

 

 

 
(250
)
 
250

 

Capital contribution received

 

 

 
452

 
(452
)
 

Other financing activities

 

 

 
(2
)
 

 
(2
)
Net cash provided by (used in) financing activities
(24
)
 
2

 
1,944

 
337

 
(3,400
)
 
(1,141
)
Effect of exchange rate changes on cash and cash equivalents

 

 

 
45

 

 
45

Net change in cash and cash equivalents

 
(33
)
 
25

 
(268
)
 

 
(276
)
Cash and cash equivalents at beginning of period

 
33

 
5

 
4,929

 

 
4,967

Cash and cash equivalents at end of period
$

 
$

 
$
30

 
$
4,661

 
$

 
$
4,691



44

X